Voxtalisib
|
VOXTALISIB
|
934493-76-2
|
Uprosertib
|
UPROSERTIB
|
1047634-65-0
|
CAL-130 Hydrochloride
|
2-[(1S)-1-[(2-氨基-9H-嘌呤-6-基)氨基]乙基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮鹽酸鹽
|
1431697-78-7
|
LY2090314
|
LY 2090314
|
603288-22-8
|
NVP-QAV-572
|
N-[2-[2-(2-氟乙基)-2H-四唑-5-基]乙基]-N'-[5-[3-氟-4-(甲基磺?;?苯基]-4-甲基-2-噻唑基]脲
|
957209-68-6
|
Phenformin hydrochloride
|
鹽酸苯乙福明
|
834-28-6
|
Pilaralisib
|
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺?;鵠苯基]-2-甲基丙酰胺
|
934526-89-3
|
VS-5584
|
VS-5584
|
1246560-33-7
|
CNX-1351
|
CNX1351
|
1276105-89-5
|
3CAI
|
2-氯-1-(1H-吲哚-3-基)-乙酮
|
28755-03-5
|
ZLN024 hydrochloride
|
ZLN-024 hydrochloride
|
1883548-91-1
|
CZC24832
|
5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺
|
1159824-67-5
|
Copanlisib dihydrochloride
|
Copanlisib
|
1402152-13-9
|
BIO-acetoxime
|
6-溴靛玉紅-3'-丙酮肟
|
667463-85-6
|
FPA-124
|
AKT 抗化劑
|
902779-59-3
|
CH5132799
|
CH5132799
|
1007207-67-1
|
OTSSP167 hydrochloride
|
OTSSP 167 鹽酸鹽
|
1431698-10-0
|
CGK733
|
CGK 733
|
905973-89-9
|
KP-23172
|
6H-INDENO[1,2-E]TETRAZOLO[1,5-B][1,2,4]TRIAZIN-6-ONE
|
1374996-60-7
|
PI4KIII beta inhibitor 3
|
4-(5-AMINO-2-PYRIDIN-3-YL-THIAZOLO[5,4-D]PYRIMIDIN-7-YL)-PIPERAZINE-1-CARBOXYLIC ACID P-TOLYLAMIDE
|
1245319-54-3
|
NU 7026
|
2-(4-嗎啉基)-4H-萘并[1,2-B]吡喃-4-酮
|
154447-35-5
|
SAR-260301
|
(S)-2-(2-(2-甲基吲哚啉-1-基)-2-氧代乙基)-6-嗎啉嘧啶-4(3H)-酮
|
1260612-13-2
|
HS-173
|
HS-173
|
1276110-06-5
|
PF-04691502
|
2-氨基-8-[反式-4-(2-羥基乙氧基)環(huán)己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮
|
1013101-36-4
|
Buparlisib Hydrochloride
|
BKM120(鹽酸鹽)
|
1312445-63-8
|
Ipatasertib dihydrochloride
|
(2S)-2-(4-氯苯基)-1-[4-[(5R,7R)-6,7-二氫-7-羥基-5-甲基-5H-環(huán)戊并嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙酮二鹽酸鹽
|
1396257-94-5
|
Alpelisib
|
阿培利司
|
1217486-61-7
|
GSK2636771
|
GSK2636771
|
1372540-25-4
|
GDC-0349
|
N-ETHYL-N'-[4-[5,6,7,8-四氫-4-[(3S)-3-甲基-4-嗎啉基]-7-(3-氧雜環(huán)丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲
|
1207360-89-1
|
WYE-687 dihydrochloride
|
WYE-687二鹽酸鹽
|
1702364-87-1
|
BX517
|
PDK1 INHIBITOR
|
850717-64-5
|
(R)-PS210
|
Propanedioic acid, 2-[(1R)-3-oxo-1-phenyl-3-[4-(trifluoroMethyl)phenyl]propyl]-
|
1410101-89-1
|
PF-4989216
|
4-(4-氰基-2-氟苯基)-2-嗎啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈
|
1276553-09-3
|
Taselisib
|
GDC 0032
|
1282512-48-4
|
GSK-3 inhibitor 1
|
3-(9-氟-1,2,3,4-四氫吡咯并[3,2,1-JK][1,4]苯并二氮雜卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮單鹽酸鹽
|
603272-51-1
|
MP7
|
PDK1 抑制劑
|
1001409-50-2
|
Palomid 529
|
PALOMID 529 (P529)
|
914913-88-5
|
GSK2334470
|
GSK2334470
|
1227911-45-6
|
Dactolisib Tosylate
|
BEZ235 對甲苯磺酸鹽
|
1028385-32-1
|
CAY10505
|
CAY10505
|
1218777-13-9
|
AS-604850
|
5-[(2,2-二氟-1,3-苯并二惡茂-5-基)亞甲基]噻唑烷-2,4-二酮
|
648449-76-7
|
AS-252424
|
5-[[5-(4-氟-2-羥基苯基)-2-呋喃基]亞甲基]-2,4-噻唑烷二酮
|
900515-16-4
|
MSC2360844
|
MSC2360844
|
1305267-37-1
|
MSC2360844 hemifumarate
|
MSC2360844 HEMIFUMARATE
|
1621688-31-0
|
IM156
|
IM156
|
1422365-94-3
|
SRX3207
|
7H-Thieno[3,2-b]pyran-7-one, 3-[4-[[4-[4-(1-azetidinylmethyl)-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]phenyl]-5-(4-morpholinyl)-
|
2254693-15-5
|
ATR inhibitor 2
|
2-氨基-6-氟-N-(5-氟-4-(4-(4-(噁丁環(huán)烷-3-基)哌嗪-1-羰基)哌啶-1-基)吡啶-3-基)吡唑并[1,5-A]嘧啶-3-甲酰胺
|
1613191-99-3
|
ASP4132
|
(6-(1-((6-甲氧基吡啶-3-基)甲基)哌啶-4-基)-1H-苯并[D]咪唑-2-基)(4-(4-(三氟甲基)芐基)哌嗪-1-基)甲酮 雙對甲苯磺酸鹽
|
1640294-30-9
|
PQR626
|
無中文名稱
|
1927857-98-4
|
TMBIM6 antagonist-1
|
1-(2-氨基苯基)-3-(3-硝基苯基)-2-丙烯-1-酮
|
123134-61-2
|
SAR502250
|
SAR502250
|
503860-57-9
|
XL388
|
[7-(6-氨基-3-吡啶基)-2,3-二氫-1,4-苯并氧氮雜卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺?;?苯基]-甲酮
|
1251156-08-7
|
Seletalisib
|
UCB5857
|
1362850-20-1
|
CC-223
|
CC-223
|
1228013-30-6
|
CC-115 hydrochloride
|
1300118-55-1
|
1300118-55-1
|
Duvelisib
|
IPI-145
|
1201438-56-3
|
Duvelisib (R enantiomer)
|
1261590-48-0
|
1261590-48-0
|
Tenalisib
|
RP6530
|
1639417-53-0
|
mTOR inhibitor-3
|
N-乙基-N'-[4-[5,6,7,8-四氫-4-[(3S)-3-甲基-4-嗎啉基]-7-(2-嘧啶基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲
|
1207358-59-5
|
KU 59403
|
KU59403
|
845932-30-1
|
SC79
|
2-氨基-6-氯-ALPHA-氰基-3-(乙氧羰基)-4H-1-苯并吡喃-4-乙酸乙酯
|
305834-79-1
|
(S)-Ceralasertib
|
(S)-CERALASERTIB
|
1352226-87-9
|
Nemiralisib
|
CS-2340
|
1254036-71-9
|
BEBT-908
|
PI3Kα 抑制劑1
|
1235449-52-1
|
PI4KIIIbeta-IN-9
|
1429624-84-9
|
1429624-84-9
|
SC66
|
SC 66
|
871361-88-5
|
VX-984
|
化合物 T11067
|
1476074-39-1
|
Metformin
|
二甲雙胍
|
657-24-9
|
MHY1485
|
MHY1485
|
326914-06-1
|
Pictilisib dimethanesulfonate
|
GDC0941
|
957054-33-0
|
KU-0063794
|
KU-0063794
|
938440-64-3
|
Akt1 and Akt2-IN-1
|
3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
|
893422-47-4
|
Buformin hydrochloride
|
鹽酸丁雙胍
|
1190-53-0
|
Sophocarpine monohydrate
|
槐果堿
|
145572-44-7
|
Cyclovirobuxine D
|
環(huán)維黃楊星 D
|
860-79-7
|
Dihydromyricetin
|
二氫楊梅素
|
27200-12-0
|
Quercetin dihydrate
|
二水槲皮素
|
6151-25-3
|
Crebanine
|
克班寧
|
25127-29-1
|
Amarogentin
|
苦杏苷
|
21018-84-8
|
Karanjin
|
干華豆晶 4
|
521-88-0
|
Euscaphic acid
|
野鴉椿酸
|
53155-25-2
|
Nepodin
|
羊蹄素
|
3785-24-8
|
Kahweol
|
咖啡豆醇
|
6894-43-5
|
(+)-Usnic acid
|
松蘿酸
|
7562-61-0
|
α-Linolenic acid
|
α-亞麻酸
|
463-40-1
|
Vaccarin
|
王不留行黃酮苷
|
53452-16-7
|
Loureirin A
|
龍血素A
|
119425-89-7
|
SAMS
|
HIS-MET-ARG-SER-ALA-MET-SER-GLY-LEU-HIS-LEU-VAL-LYS-ARG-ARG
|
125911-68-4
|
ARV-771
|
ARV-771
|
1949837-12-0
|
Sonolisib
|
PX-866
|
502632-66-8
|
7-Methoxyisoflavone
|
7-甲氧基異黃酮
|
1621-56-3
|
Glaucocalyxin A
|
藍萼甲素
|
79498-31-0
|
BF738735
|
化合物BF738735
|
1436383-95-7
|
Marein
|
馬里苷
|
535-96-6
|
3α-Hydroxymogrol
|
3Α-羥基羅漢果醇
|
1343402-73-2
|
Heterophyllin B
|
太子參環(huán)肽B
|
145459-19-4
|
Hederacolchiside A1
|
黑海常春藤苷A1
|
106577-39-3
|
K-80003
|
1292821-90-9
|
1292821-90-9
|
MT 63-78
|
5-{2',6'-dihydroxy-[1,1'-biphenyl]-4-yl}-1H-indole-3-carbonitrile
|
1179347-65-9
|
Crosstide
|
模擬肽CROSSTIDE
|
171783-05-4
|